What is SENS's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 0.47B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for SENS?

P/E (TTM) is n/a and 52-week range is $4.79 to $10.64 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s SENS figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for SENS?

The company profile lists revenue (TTM) near $35M, net income (TTM) near $-7.91B, EPS (TTM) near $-2.24 when available from the market-data feed. Figures are informational and may lag live markets.

Where is Senseonics Holdings Inc based, and what identifiers does Chartloom list?

The company context section lists headquarters in Germantown, Maryland, US, 41.8M shares outstanding, ISIN US81727U3032 when available from company profile and filing metadata.

Senseonics Holdings Inc

$SENS

Health Care · Health Care Equipment & Supplies

IR Run Scenarios

$8.98

-0.44%

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

Senseonics Holdings, Inc. is a medical technology company, which engages in the development and manufacture of glucose monitoring products. The company is headquartered in Germantown, Maryland and currently employs 130 full-time employees. The company went IPO on 2015-03-04. Its glucose monitoring (CGM) systems Eversense 365 and Eversense E3 include a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. Its CGM systems are indicated for continually measuring glucose levels for up to 365 days for Eversense 365 and 180 days for Eversense E3 in persons with diabetes age 18 and older. Eversense consists of three primary components: a small sensor inserted subcutaneously under the skin by a healthcare provider; an external removable smart transmitter that receives, assesses and relays data from the sensor and provides vibratory alerts; and a mobile app that receives data from the transmitter and provides real-time glucose readings, alerts and other data the person's mobile device.

Employees

130

Website

www.senseonics.com/

IPO

2015-03-04

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)